venBio

What they do

VenBio invests in promising companies at various stages: from early to late stages, and from academic startups to spinouts. It tends to lead most of its investments, and it enjoys building syndicates and teams. The company is mindful of potential acquisition partners from the outset, and it ensures that its companies are best positioned to meet their requirements. This includes IP, CMC, and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations. Its team’s expertise and involvement help companies make a bigger impact, and this leads to impactful and lasting relationships with the leaders that they work with.

What they look for

venBio focuses on novel therapeutics with meaningful impact on patient care, identifying and supporting innovative solutions while structuring development plans with potential acquisition partners in mind from the outset.

Stage

Seed

Sectors

Healthcare

Based

San Francisco, US